Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up

Br J Psychiatry. 2003 Apr:182:303-11. doi: 10.1192/bjp.182.4.303.

Abstract

Background: Evidence for the efficacy of cognitive-behavioural therapy for schizophrenia is promising but evidence for clinical effectiveness is limited.

Aims: To test the effectiveness of cognitive-behavioural therapy delivered by clinical nurse specialists in routine practice.

Method: Of 274 referrals, 66 were allocated randomly to 9 months of treatment as usual (TAU), cognitive-behavioural therapy plus TAU (CBT) or supportive psychotherapy plus TAU (SPT) and followed up for 3 months.

Results: Treatment effects were modest but the CBT condition gave significantly greater improvement in overall symptom severity than the SPT or TAU conditions combined (F (1,53)=4.14; P=0.05). Both the CBT and SPT conditions combined gave significantly greater improvement in severity of delusions than did the TAU condition (F (1,53)=4.83; P=0.03). Clinically significant improvements were achieved by 7/21 in the CBT condition (33%), 3/19 in the SPT condition (16%) and 2/17 in the TAU condition (12%).

Conclusions: Cognitive-behavioural therapy delivered by clinical nurse specialists is a helpful adjunct to routine care for some people with chronic psychosis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / therapeutic use
  • Attitude to Health
  • Chlorpromazine / therapeutic use
  • Chronic Disease
  • Cognitive Behavioral Therapy / methods*
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Nursing Care / methods
  • Professional-Patient Relations
  • Psychiatric Status Rating Scales
  • Psychotherapy / methods
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / therapy*
  • Schizophrenia / drug therapy
  • Schizophrenia / therapy
  • Schizophrenia, Paranoid / drug therapy
  • Schizophrenia, Paranoid / therapy
  • Severity of Illness Index

Substances

  • Antipsychotic Agents
  • Chlorpromazine